Skip to main content
. 2019 Jan-Feb;29(1):65–69. doi: 10.4103/ijn.IJN_384_17

Table 2.

Reported cases of primary allograft dysfunction due to myeloma cast nephropathy

Case report Age/gender Etiology of ESRD Time of diagnosis Light chain Treatment Outcome
Geiger et al.[2] 55 years/female Unknown POD 81 Lambda Melphalan + prednisone Graft nephrectomy on POD 83
Foster et al.[3] 63 years/male Diabetic nephropathy POD 35 Kappa Thalidomide + dexamethasone + melphalan + prednisone HD-dependent at POD 120
Perkowska-Ptasinska et al.[4] 51 years/male Unknown POD 21 Lambda Not available Graft nephrectomy on POD 51
Goel et al.[5] 72 years/female Unknown POD 26 Lambda Plasmapheresis + bortezomib + dexamethasone Recovery of graft function by POD 90
Lingaraj et al.[1] 45 years/male Unknown POD 3 Lambda Plasmapheresis + bortezomib + dexamethasone Dialysis dependent and succumbed to sepsis on POD 37
Index case 63 years/male Diabetic nephropathy POD 14 Lambda Plasmapheresis + bortezomib + prednisolone Dialysis dependent and had sudden cardiac death on POD 22

POD: Postoperative day, HD: Hemodialysis, ESRD: End stage renal disease